Mustang Bio, Inc. (MBIO) insider buying and SEC filings
Mustang Bio, Inc. · CIK 1680048
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$241
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Dec 30, 2025 | Sale | Neil Herskowitz (Director) sold 247 shares at $0.9600 ($237). Holdings down 63% to 145 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
| Dec 30, 2025 | Sale | Adam J. Chill (Director) sold 4 shares at $0.9500 ($4). Holdings down 1% to 375 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
| Dec 30, 2025 | Purchase (code P) | David Jin (Director) bought 247 shares at $0.9600 ($237), reported as a purchase (code P). Holdings up 633% to 286 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
2 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MBIO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.